Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Freedman

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Investigation|January 5, 2005
Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?Vinayakumar Siragam, Davor Brinc, Andrew R Crow, et al.
Haematologica|December 10, 2009
The GPIIbIIIa antagonist drugs eptifibatide and tirofiban do not induce activation of apoptosis executioner caspase-3 in resting platelets but inhibit caspase-3 activation in platelets stimulated with thrombin or calcium ionophore A23187Valery Leytin, Asuman Mutlu, Sergiy Mykhaylov, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 25, 2009
Mitochondrial control of platelet apoptosis: effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition poreValery Leytin, David J Allen, Asuman Mutlu, et al.
Thrombosis and Haemostasis|August 28, 2007
Persistence of phosphatidylserine exposure on activated platelets in vivo in rabbitsMargaret L Rand, Hong Wang, K W Annie Bang, et al.
Transfusion|June 20, 2008
A novel immunosuppressive pathway involving peroxynitrite-mediated [corrected] nitration of platelet antigens within antigen-presenting cellsJohn W Semple, Edwin R Speck, Antonio Fabron, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individualsQigui Yu, Jenny X Gu, Colin Kovacs, et al.
Transfusion Medicine Reviews|April 15, 2005
Proceedings of a consensus conference: towards an understanding of TRALIMindy Goldman, Kathryn E Webert, Donald M Arnold, et al.
Blood|July 25, 2006
Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodiesMichelle Lee Webster, Ebrahim Sayeh, Min Crow, et al.
Haematologica|February 3, 2009
In HPA 1a-immunized women the decrease in anti-HPA 1a antibody level during pregnancy is not associated with anti-idiotypic antibodiesJens Kjeldsen-Kragh, Michael Kim, Mette Kjaer Killie, et al.
Immunology|February 13, 2008
Immunoglobulin G-mediated regulation of the murine immune response to transfused red blood cells occurs in the absence of active immune suppression: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the fetus and newborn?Davor Brinc, Hoang Le-Tien, Andrew R Crow, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Investigation|January 5, 2005
Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?Vinayakumar Siragam, Davor Brinc, Andrew R Crow, et al.
Haematologica|December 10, 2009
The GPIIbIIIa antagonist drugs eptifibatide and tirofiban do not induce activation of apoptosis executioner caspase-3 in resting platelets but inhibit caspase-3 activation in platelets stimulated with thrombin or calcium ionophore A23187Valery Leytin, Asuman Mutlu, Sergiy Mykhaylov, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 25, 2009
Mitochondrial control of platelet apoptosis: effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition poreValery Leytin, David J Allen, Asuman Mutlu, et al.
Thrombosis and Haemostasis|August 28, 2007
Persistence of phosphatidylserine exposure on activated platelets in vivo in rabbitsMargaret L Rand, Hong Wang, K W Annie Bang, et al.
Transfusion|June 20, 2008
A novel immunosuppressive pathway involving peroxynitrite-mediated [corrected] nitration of platelet antigens within antigen-presenting cellsJohn W Semple, Edwin R Speck, Antonio Fabron, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individualsQigui Yu, Jenny X Gu, Colin Kovacs, et al.
Transfusion Medicine Reviews|April 15, 2005
Proceedings of a consensus conference: towards an understanding of TRALIMindy Goldman, Kathryn E Webert, Donald M Arnold, et al.
Blood|July 25, 2006
Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodiesMichelle Lee Webster, Ebrahim Sayeh, Min Crow, et al.
Haematologica|February 3, 2009
In HPA 1a-immunized women the decrease in anti-HPA 1a antibody level during pregnancy is not associated with anti-idiotypic antibodiesJens Kjeldsen-Kragh, Michael Kim, Mette Kjaer Killie, et al.
Immunology|February 13, 2008
Immunoglobulin G-mediated regulation of the murine immune response to transfused red blood cells occurs in the absence of active immune suppression: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the fetus and newborn?Davor Brinc, Hoang Le-Tien, Andrew R Crow, et al.
Pageof 13